–
Статьи в журналах
-
- 2020 Empagliflozin improves functional capacity and LV diastolic function in patients with HFpEF and type-2 diabetes mellitus: preliminary results of randomized open-label trial
- Borisov A., Ovchinnikov A., Zherebchikova K., Ryabtseva O., Svirida O., Ageev F.
- в журнале European Journal of Heart Failure, издательство Elsevier BV (Netherlands), с. 236 DOI